Page last updated: 2024-09-03

502u83 and Cancer of Pelvis

502u83 has been researched along with Cancer of Pelvis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Vries, EG; Mulder, NH; Nethersell, AB; van der Graaf, WT; Zijlstra, JG	1

Trials

1 trial(s) available for 502u83 and Cancer of Pelvis

Article	Year
In vitro and in vivo studies on the action of BW502U83, an arylmethylaminopropanediol. Anti-cancer drugs, 1995, Volume: 6, Issue:1 Topics: Adenocarcinoma; Adult; Anthracenes; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carcinoma, Hepatocellular; Colonic Neoplasms; DNA Damage; DNA, Neoplasm; Drug Resistance, Multiple; Feasibility Studies; Female; Humans; Injections, Intra-Arterial; Intercalating Agents; Liver Neoplasms; Male; Neoplasm Proteins; Pelvic Neoplasms; Sarcoma; Tumor Cells, Cultured	1995

Article

Year

In vitro and in vivo studies on the action of BW502U83, an arylmethylaminopropanediol.

Anti-cancer drugs, 1995, Volume: 6, Issue:1

Topics: Adenocarcinoma; Adult; Anthracenes; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carcinoma, Hepatocellular; Colonic Neoplasms; DNA Damage; DNA, Neoplasm; Drug Resistance, Multiple; Feasibility Studies; Female; Humans; Injections, Intra-Arterial; Intercalating Agents; Liver Neoplasms; Male; Neoplasm Proteins; Pelvic Neoplasms; Sarcoma; Tumor Cells, Cultured

1995